The objective: to identify factors influencing the development of dyspepsia in children during treatment with anti-tuberculosis drugs. Results: out 243 chemotherapy, 22.6% developed as an adverse reaction. Risk significantly associated were follows: formula feeding at birth, comorbidities gastrointestinal tract, decreased total protein and elevated leukocyte counts by admission hospital, tuberc...
